4
Changes in Ownership
Yarrow Bioscience, Inc. Filed Acc 0001209191-20-061177
Chief Commercial Officer acquired 7,838 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wiley Matthew T. · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-30 | Grant or award : show line 1 in the form | +7,838 | $1.45 | $11,326 | 358,722 | D |
Loading xslF345X03/doc4.xml…